Altogen Biosystems is a recognized developer and laboratory
for genetic research. Custom research offers and additional experiments include
xenografts, toxicology assays, 28-day generation of stably-transfected cells,
RNAi testing and more. Dedicated to assisting pharmaceutical companies with
cutting-edge and specialized services, Altogen Biosystems endeavors to optimize
modern laboratory discoveries. Visit Altogen’s catalog for brain
cancer xenograft models and other tools for preclinical research and drug
development.
Brain tissue removed from an albino house mouse (Mus musculus) with neuroblastoma was first used to establish the Neuro-2a cell line. These cells exhibit amoeboid and neuronal stem cell morphology, they also produce a bountiful amount of microtubular protein within the body. This cell line is good as a transfection host, as it is susceptible to the human polio virus 1, vesicular stomatitis virus and the herpes simplex virus. Altogen Biosystems manufactures a transfection reagent for Neuro-2a that meticulously targets the neuroblastoma cells for further research of carcinogenic brain tumors. Transfection Reagent for Neuro-2a Cells (Neuroblastoma Cells, CCL-131)
Comments
Post a Comment